Global Digital Pathology Market

Digital Pathology Market: Insights

In the forecast timeframe from 2020 to 2026, a higher compound annual growth rate will raise the global demand for digital pathology. Digital pathology is allowed by computer technology as an image-based information environment that enables information created by a digital slide to be handled. The digitization of pathology has contributed to the automation of examinations during the diagnosis of diseases, among several other applications. Some of the major reasons projected to raise demand for digital pathology are the increased usage of digital pathology to boost laboratory quality, along with the growing demand for customized medicine. Digital pathology applications provide computer image screening & examination, high-resolution sample scanning, and digital slide storage electronically, allowing pathologists to cross-examine slides without tangible evidence. Moreover, the increasing prevalence of cancer globally is also steering the industry's growth. However, the lack of qualified laboratory pathologists and the increased price of automated pathology systems that are likely to adversely impede market growth during the projected period.

Digital Pathology Market: By Application

This market can be described by four fields, teleconsultation, training & education, drug development, and disease detection, depending on the application. It was expected that the drug development application market will contribute more to global revenues in this field of business. This is due to the rise in R&D investment, fueled by the need for multiple preclinical and clinical trials undertaken during the phase of drug discovery and development.

Digital Pathology Market: By Product

The sector is categorized into product-based segments: scanners, storage systems, software, and communication systems. The division of scanners is expected to add more to global market sales across all products. This is attributable to the growing adoption of applications for digital pathology worldwide. Moreover, the increased use of scanners in pathology laboratories is further driving market development.

Digital Pathology Market: By End-User

This market can be represented in three categories according to the end-user analysis, namely: pharmaceutical & biotechnology firms, hospitals, and reference labs, academic and research institutes. The division of pharmaceutical & biotechnology corporations is expected to contribute more to the industry’s worldwide revenue across all end-users. This is due to the growing use of automated pathology for trials in drug development and research on drug toxicology.

Digital Pathology Market: By Region

Centered on the local region, the Digital Pathology sector is divided into, among others, Europe, North America, Asia Pacific, and the Middle East & Africa, others. The North American area is expected to add to global revenues over the forecast timeframe. This is owing to the large per capita annual healthcare investment by the US and Canadian governments, which is due to quick usability and fast penetration of modern analytical technology. The Asia-Pacific region is expected to see substantial growth at a high CAGR pace in emerging regions. The rising food security issues in India and the development in the biotechnology and pharmaceutical industries are some of the factors influencing the growth of the sector.

Digital Pathology Market: Share & Competitor Analysis

The key players competing in this market are Leica Biosystems, Hamamatsu Photonics, Sectra Ab, Apollo Enterprise Imaging Corp., Huron Digital Pathology, Corista, Objective Pathology Service, Glencoe Software, Inc., Koninklijke Philips, F. Hoffmann-La Roche Ltd., Dhistech Inspirata, Inc., and Proscia, Inc. among others.

Please note: This is not an exhaustive list of companies profiled in the report.

In May 2020, Leica Biosystems launched its new product i.e., the Aperio GT 450.

Check the Press Release on Global Digital Pathology Market Report